Sunshine Guojian Pharmaceutical Shanghai (SHA:688336) appointed Niu Hongmei as chief financial officer to succeed Sun Yongzhi, who resigned due to a job transfer.
Niu joined the drugmaker as financial manager in June 2017, according to a Wednesday filing with the Shanghai bourse.
Sun continues to serve as a director of Sunshine Guojian Pharmaceutical Shanghai.
Shares of the company closed 1% lower Wednesday.